Upload
PPT-Prevention of Serious Adverse Events Following Angiography (PRESERVE) Trial

PPT-Prevention of Serious Adverse Events Following Angiography (PRESERVE) Trial

Author : OneAndOnly | Published Date : 2022-08-04

VA Cooperative Studies Program Trial 578 ContrastAssociated Acute Kidney Injury CAAKI Common post angiography amp associated with death dialysis progressive CKD

nac aki aki nac endpoint angiography trial nacl comparisons preserve pre nahco groups placebo outcomes angio prevention

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Prevention of Serious Adverse Events Fol..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Prevention of Serious Adverse Events Following Angiography (PRESERVE) Trial: Transcript

Download Document

Here is the link to download the presentation.
"Prevention of Serious Adverse Events Following Angiography (PRESERVE) Trial"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents

A series of randomised controlled N-of 1 trials in patients

A series of randomised controlled N-of 1 trials in patients
Remote Monitoring of Adverse Events

Remote Monitoring of Adverse Events
Lessons to learn from the reporting of adverse events in RCTs published in four high impact

Lessons to learn from the reporting of adverse events in RCTs published in four high impact
A series of randomised controlled N-of 1 trials in patients who have discontinued or are

A series of randomised controlled N-of 1 trials in patients who have discontinued or are
MODULE 3 Adverse events following immunizationMODULE 3Adverse events f

MODULE 3 Adverse events following immunizationMODULE 3Adverse events f
On behalf of the TRILOGY ACS Investigators

On behalf of the TRILOGY ACS Investigators
Example of a Big Title Example of smaller subtitle

Example of a Big Title Example of smaller subtitle
PROFILE - Trial Design A randomised, multi-centre, biomarker-stratified open-label trial

PROFILE - Trial Design A randomised, multi-centre, biomarker-stratified open-label trial
Neuropsychiatric manifestations and

Neuropsychiatric manifestations and
PhUSE US Connect 2018

PhUSE US Connect 2018
Fundamentals of Fluorescein AngiographyTimothy J Bennett CRA OCTC

Fundamentals of Fluorescein AngiographyTimothy J Bennett CRA OCTC
A Randomized Controlled Trial of Influenza Vaccine to Prevent Adverse Vascular

A Randomized Controlled Trial of Influenza Vaccine to Prevent Adverse Vascular
Adverse Events and Serious Adverse Events

Adverse Events and Serious Adverse Events